These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19537631)

  • 1. The non-small-cell lung cancer drug market.
    Nawaz K; Webster RM
    Nat Rev Drug Discov; 2023 Apr; 22(4):264-265. PubMed ID: 36690751
    [No Abstract]   [Full Text] [Related]  

  • 2. Cysteine substitutants emerge in lung cancer proteomes during arginine restriction.
    Hsu DJ; Tavazoie SF
    Mol Cell; 2024 May; 84(10):1819-1821. PubMed ID: 38759621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From ESMO 2023: advances in lung cancer.
    Sidaway P
    Nat Rev Clin Oncol; 2024 Jan; 21(1):4. PubMed ID: 37923903
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimal therapy for unresectable stage III non-small-cell lung cancer.
    Vokes EE
    J Clin Oncol; 2005 Sep; 23(25):5853-5. PubMed ID: 16087940
    [No Abstract]   [Full Text] [Related]  

  • 5. Will future progress in non-small-cell lung cancer be step by step... or by leaps and bounds?
    Movsas B
    J Clin Oncol; 2005 Sep; 23(25):5859-61. PubMed ID: 16087952
    [No Abstract]   [Full Text] [Related]  

  • 6. Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure?
    Socinski MA
    J Clin Oncol; 2009 Jul; 27(20):3268-70. PubMed ID: 19470913
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advanced lung cancer: progress in individualized therapy].
    Bischoff A
    MMW Fortschr Med; 2009 May; 151(21):20. PubMed ID: 19537631
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
    Danesi R; de Braud F; Fogli S; de Pas TM; Di Paolo A; Curigliano G; Del Tacca M
    Pharmacol Rev; 2003 Mar; 55(1):57-103. PubMed ID: 12615954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update in the treatment and molecular biology of non-small cell lung cancer.
    Erlich R; Levitt ML
    Compr Ther; 1995 Aug; 21(8):445-57. PubMed ID: 8536445
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenomics in non-small-cell lung cancer chemotherapy.
    Danesi R; Pasqualetti G; Giovannetti E; Crea F; Altavilla G; Del Tacca M; Rosell R
    Adv Drug Deliv Rev; 2009 May; 61(5):408-17. PubMed ID: 19292993
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.